What happened?
Shares of healthcare solutions provider Solventum (NYSE: SOLV) jumped 5% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year adjusted earnings per share guidance.
According to a company press release, Solventum reported third-quarter 2026 revenue of $1.95 billion and adjusted earnings per share of $1.45. The company also concluded its enterprise resource planning system cutovers and exited approximately 90% of its transition service agreements with 3M. Looking ahead, the company updated its full-year 2026 outlook. It raised its adjusted earnings per share guidance to between $7.20 and $7.30, while projecting full-year organic revenue growth toward the upper end of its 2.5% to 3.0% range.
After the initial pop, the shares cooled down to $91.19, up 4.6% from the previous close.
Is now the time to buy Solventum? Access our full analysis report here, it’s free.
What is the market telling us
Solventum’s shares are not very volatile and have only had 7 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 8 months ago when the stock dropped 4.8% on the news that a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at the wholesale level, increased by 0.5% in January, significantly higher than the 0.3% anticipated by economists.
More concerning was the core PPI, which excludes volatile food and energy prices, as it surged by 0.8%, far exceeding the expected 0.3% rise. This data suggests that inflation may be more entrenched than previously thought, potentially impacting future interest rate decisions. In response to the news, major market indices, including the S&P 500, Dow Jones, and Nasdaq, all traded sharply lower as investors reassessed the economic outlook.
Solventum is up 15.4% since the beginning of the year, and at $91.19 per share, it is trading close to its 52-week high of $92.44 from September 2026. Investors who bought $1,000 worth of Solventum’s shares at the IPO in March 2024 would now be looking at an investment worth $1,140.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
